Gruppo Oncologico Del Nord-ovest

This study is testing if using a stronger combination of chemotherapy drugs after colon cancer surgery can better prevent the cancer from coming back. It uses a sensitive blood test to find tiny traces of cancer DNA and guide treatment decisions. The trial involves patients with …

This study is testing whether combining three existing cancer drugs is safe and effective for people with advanced colorectal cancer that has spread. The trial is for patients who cannot receive more intensive chemotherapy. Researchers will first find the safest dose, then see ho…

This study is testing if a specific drug combination (encorafenib plus cetuximab) can work a second time for patients with a certain type of advanced colorectal cancer. It will enroll 16 patients whose cancer initially responded to this same treatment but later stopped working. D…

This study is testing whether a short, one-cycle course of combined chemotherapy and immunotherapy given before surgery can help treat Merkel cell carcinoma, a rare and aggressive skin cancer. It involves 36 adults with operable cancer who have not had prior systemic treatment. T…

This study aims to find the best order to give two different cancer drugs to patients with advanced colorectal cancer that has stopped responding to standard treatments. Researchers are comparing whether starting with panitumumab followed by regorafenib works better than the reve…